On April 10, 2016, sponsored by the China Red Cross Foundation's Slow Diseases Care Fund, the Education Management Group of the Diabetes Branch of the Chinese Medical Association provided academic support. Bayer Health & Medical Co., Ltd. supported the large-sugar medical APP to provide mobile medical services. China's postprandial blood glucose optimization management platform project was launched in Yangzhou, Jiangsu.
It is reported that the "Power+ China Postprandial Blood Glucose Optimization Management Platform Project" will carry out in-hospital and post-prandial blood glucose optimization management in 220 general hospitals nationwide, promoted by 1000 diabetes specialists, and through the Chinese postprandial blood glucose optimization management platform. On the health consultation, as well as offline teaching activities, a three-month postprandial blood glucose optimization management service to guide patients to scientific self-glycemic management. It is expected that about 80,000 patients with elevated postprandial blood glucose will be benefited from patients who do not meet postprandial blood glucose levels.
Bayer is committed to promoting diabetes patient management and patient education in China. Since 2006, he has made many attempts in the field of diabetes management and education. In this “Power+ China Postprandial Blood Glucose Optimization Management Platform†project, Bayer chose to use the mobile medical platform to provide diabetes patients and patient management in a more diverse and individualized manner, especially after meals. Management optimization and compliance management.
It is understood that the project's mobile medical services to undertake the party's major sugar doctors mainly provide five services for doctors, including research, brand building, patient management, sunshine income and social life. In the early stage of product design, the big sugar doctor is positioned in the hospital for medical exchanges and follow-up, using professional medical knowledge, combined with the advantages of the Internet, to achieve more intelligent disease control and college outpatient follow-up. Gu Bin, the founder and chairman of the company, said that so far the number of doctors on the big sugar medical platform has reached 15,000, and the number of serving patients is close to 300,000.
Individualized settings that help with glycemic management goals and individualized choices for treatment
According to the Diabetes Map released by the International Diabetes Federation (IDF) in 2015, the number of people with diabetes in China has reached 100 million, which means that one in four people worldwide are in China. Due to the Chinese genotype, beta cell function and other characteristics of India, Chinese patients with diabetes are more likely to have elevated postprandial blood glucose. Epidemiological data indicate that 82% of diabetic patients show elevated postprandial blood glucose. It is important to note that in newly diagnosed diabetic patients, up to 47% of patients are “simple†postprandial blood glucose elevations and are younger, with more than half of the patients under 50 years of age.
As postprandial blood glucose increases, it can significantly increase the macrovascular complications of diabetes, such as myocardial infarction, the risk of cardiac death, and is closely related to complications such as retinopathy and chronic kidney disease. However, unlike fasting blood glucose, the detection of postprandial blood glucose needs to be performed 2 hours after the meal. Because it is very limited in the hospital, most patients mainly conduct self-monitoring monitoring at home. In addition, postprandial blood glucose is not only related to drugs, but also closely related to the patient's diet management and exercise management. Therefore, for patients with type 2 diabetes, especially those with new experience in self-glycemic management, postprandial blood glucose monitoring and compliance have greater challenges, and more need to strengthen out-of-hospital management.
Based on such challenges, in 2015, led by Professor Yiyi Ming, the director of the Endocrinology Society of the Chinese Medical Association, more than 20 experts in the field of diabetes in China, such as Ji Linong and Zhu Dalong, participated in the formulation of the consensus on postprandial hyperglycemia management in Chinese patients with type 2 diabetes. The emphasis on the urgency of postprandial blood glucose management, and further clarified the target value of postprandial blood glucose based on the individual characteristics of the type of type 2 diabetes patients, the length of the disease, the duration of treatment, and the prevention of hypoglycemia. Specifically, the postprandial blood glucose routine goal is only no more than 10.0mmol / l, and for patients with new diagnosis, shorter duration, and younger age, because of the longer life expectancy, for better prognosis, postprandial blood glucose needs avenue More stringent target values ​​should be controlled below 7.8 mmol/l.
This also means that endocrinologists often need to face multiple different types of diabetic patients, and each diabetic patient's disease characteristics, treatment market conditions and expectations will be different. Therefore, it is very important to improve the individualized settings of blood glucose management goals and the individualized choice of treatment. It can effectively ensure the stable blood glucose level of domestic patients and reduce the occurrence of complications. Based on this, in order to further cope with the challenges of post-prandial blood glucose management and the consensus of blood glucose experts after the meal, the China Red Cross Foundation launched the China Postprandial Blood Sugar Optimization Management Platform Project.
According to Professor Guo Xiaoyu, head of the Education and Management Section of the Diabetes Branch of the Chinese Medical Association, “Patients can easily record blood glucose data with the Power+ China Postprandial Blood Glucose Optimization Platform APP. Online and exclusive doctors can conduct interactive health consultations and receive more individuals. Diabetes education; doctors can organize online and offline education through the Chinese postprandial blood glucose optimization management platform, and can also push the articles according to the individual patient's situation. With the efficiency and convenience of new media, patients enjoy personalized blood sugar. At the same time of management, the doctor also closely monitors the patient's blood sugar status, and develops a blood sugar management plan for the patient, so that both the doctor and the patient can participate closely, so that the patient's postprandial blood glucose management benefits from mobile medical treatment."
Peptides Powder is also called Nano Oligopeptide Collagen (OCO, Nano active Oligopeptide Collagen, or Nano Collagen for short), also known as Oligopeptide, micro peptide, short peptide. Small peptides generally refer to oligopeptides composed of 2-3 amino acids, with an average molecular weight of about 300 daltons. The final products of protein (collagen) digestion in the digestive tract are usually small peptides rather than free amino acids. Small peptides can be completely absorbed and enter the blood circulation in the form of two or three peptides. Small peptides play an important role in protein nutrition.
peptides powder buy,peptide powder benefits,peptides powder for sale,peptides powder for bodybuilding
Shaanxi YXchuang Biotechnology Co., Ltd , https://www.peptide-nootropics.com